PARIS – The Paris Stock Exchange ended slightly 0.18% on Wednesday, after a session without a major catalyst, in a prudent market on the eve of the entry of customs duties imposed by Donald Trump.
The CAC 40 star index won 13.99 points and established 7,635.03 points at the fence. Tuesday, he had lost 10.97 points (-0.14%) to 7,621.04 points.
“The news that dominates the markets is the implementation of customs duties expected tomorrow. We are not immune to a new change on this subject, ”comments Frédéric Ruf, expert in financial investments at Milleis Banque, highlighting the prudence of investors on the eve of this deadline.
These new taxes on imports will take effect, for the majority of the countries concerned, on August 7, and not Friday August 1 as an initially expected, in order to allow customs to organize for their collection, assures the White House.
But this postponement offers a window for final talks, want to believe several countries, including Switzerland, which has been surprised by a 39% surcharge on its products imported into the United States, a figure much higher than 15% that strike the European Union.
“We must also keep in mind that the deadline for negotiations for China is coming next week,” said Frédéric Ruf.
After facing himself with surcharge, the first two economic powers in the world accepted a commercial truce until August 12, bringing their respective customs duties to 10% on American products and 30% on Chinese products.
The session was also led by the publication of several business results elsewhere in Europe.
“There is a certain asymmetry in the reaction of the markets: when the results are good, the titles are progressing little; On the other hand, disappointments cause sensitive drops, ”retains Frédéric Ruf.
Decrease pharmaceutics
French values in the pharmaceutical sector have been drawn down by the publication of the results of the Danish Novo Nordisk, Mother of Antidiabetics Ozempic, sanctioned by the Copenhagen Stock Exchange (-5.36% to 288.15 Danish crowns, or 38.61 euros).
At the Paris rating, Sanofi abandoned 2.88% to 79.67 euros, Eurofins sold 3.00% to 64.60 euros, Sartorius Stedim Biotech dropped 2.56% to 165.55 euros, biomperieux 1.84% to 122.40 euros.
In addition, the sector was still struck by concern about Donald Trump’s ambitions to lower medication prices in the United States.
In early July, Donald Trump said he would impose a 200% surcharge on pharmaceutical products imported into the United States if production was not quickly repatriated to American soil.
Euronext CAC40
© Agence France-Presse
